Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research

    #687806

    IATE #3638784
    dreasacht bhrú Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Tacú le taighde agus nuálaíocht theicneolaíoch le dreasachtaí brú chun ionfhabhtuithe i measc daoine de bharr pataiginí atá frithsheasmhach in aghaidh ábhair fhrithmhiocróbacha a bhrath, a chosc agus a chóireáil, lena n-áirítear comhpháirtíocht Eorpach a bhunú agus infheistíocht shuntasach a dhéanamh in FSFM ‘Aon Sláinte Amháin’ chun go bhféadfar taighde agus nuálaíocht trasearnálach a chomhordú, a ailíniú agus a chistiú.' Reference "Moladh maidir le dlús a chur le gníomhaíochtaí an Aontais chun an frithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha a chomhrac trí chur chuige Aon Sláinte Amháin 2023/C 220/01, CELEX:32023H0622(01)/GA"
    brúdhreasacht Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Push-Anreiz
    de
    push incentive
    en
    Definition incentive given to companies to invest in developing new antimicrobials, which lowers the cost of developing a new medicinal product Reference "COM-EN based on:Christine Årdal, John-Arne Røttingen, Aleksandra Opalska, et al., 'Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance' (8.3.2023), Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1378–1382"
    Comment "Funding for push incentives reduces the overall cost of research and development (R&D), and pull incentives ensure a viable market."